Aceclofenac

Jump to: navigation, search
Aceclofenac
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alberto Plate [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Aceclofenac is a Non Steroidal Anti-inflamatory Drug (NSAID) that is FDA approved for the treatment of rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and periarthritis of scapulohumerous, lumbago, ischiadynia, pain caused by nonaticular rheutism. Common adverse reactions include dyspepsia, abdominal pain, nausea, rash, ruber, urticaria, symptoms of enuresis, headache, dizziness, and drowsiness.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

  • The recommended dose is 200 mg daily, taken as one dose (every 24 hours). However, the dose and dose frequency of Aceclofenac can be modified under the supervison of physician or pharmacist.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Aceclofenac in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Aceclofenac in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

The dosage and indication is not established yet for children with less than 6 years old.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Aceclofenac in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Aceclofenac in pediatric patients.

Contraindications

Aceclofenac is contraindicated in patients with:

Warnings

Adverse Reactions

Clinical Trials Experience

Postmarketing Experience

There is limited information regarding Aceclofenac Postmarketing Experience in the drug label.

Drug Interactions

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • Since there is no information on the safe use of Aceclofenac during pregnancy and lactation, the use of Aclofenac should therefore be avoided in pregnancy and lactation.


Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Aceclofenac in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Aceclofenac during labor and delivery.

Nursing Mothers

  • Since there is no information on the safe use of Aceclofenac during pregnancy and lactation, the use of Aceclofenac should therefore be avoided in pregnancy and lactation.

Pediatric Use

  • The dosage and indication is not established yet for children with less than 6 years old.

Geriatic Use

There is no FDA guidance on the use of Aceclofenac in geriatric settings.

Gender

There is no FDA guidance on the use of Aceclofenac with respect to specific gender populations.

Race

There is no FDA guidance on the use of Aceclofenac with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Aceclofenac in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Aceclofenac in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Aceclofenac in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Aceclofenac in patients who are immunocompromised.

Administration and Monitoring

Administration

There is limited information regarding Aceclofenac Administration in the drug label.

Monitoring

There is limited information regarding Aceclofenac Monitoring in the drug label.

IV Compatibility

There is limited information regarding the compatibility of Aceclofenac and IV administrations.

Overdosage

  • There are no human data available on the consequences of Aceclofenac overdosage. If overdosage is observed, therapeutic measures should be taken according to symptoms; supportive and symptomatic treatment should be given for complications such as hypotension, gastrointestinal irritation, respiratory depression, and convulsions.

Pharmacology

Aceclofenac structure.png
Aceclofenac
Systematic (IUPAC) name
2-[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxyacetic acid
Identifiers
CAS number 89796-99-6
ATC code M01AB16 M02AA25 (WHO)
PubChem 71771
Chemical data
Formula C16H13Cl2NO4 
Mol. mass 354.18472 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability ?
Metabolism ?
Half life ?
Excretion ?
Therapeutic considerations
Pregnancy cat.

?

Legal status

POM(UK)

Routes oral, topical

Mechanism of Action

There is limited information regarding Aceclofenac Mechanism of Action in the drug label.

Structure

Aceclofenac structure.png

Pharmacodynamics

There is limited information regarding Aceclofenac Pharmacodynamics in the drug label.

Pharmacokinetics

There is limited information regarding Aceclofenac Pharmacokinetics in the drug label.

Nonclinical Toxicology

There is limited information regarding Aceclofenac Nonclinical Toxicology in the drug label.

Clinical Studies

There is limited information regarding Aceclofenac Clinical Studies in the drug label.

How Supplied

  • 10 Blister Packs with 10 Tablets in each Blister Pack

Storage

  • Preserve in tight containers. Store at room temperature not exceeding 30oC. Three (3) years from manufacturing date. Do not exceed the expiry date for use printed on the box.

Images

Drug Images

Package and Label Display Panel

Aceclofenac Appearance.png
Aceclofenac Package.png
This image of the FDA label is provided by the National Library of Medicine.

Patient Counseling Information

There is limited information regarding Aceclofenac Patient Counseling Information in the drug label.

Precautions with Alcohol

Alcohol-Aceclofenac interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

Look-Alike Drug Names

There is limited information regarding Aceclofenac Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.





Linked-in.jpg